[1]
Singh, S. et al. 2013. Clinical significance of PARP-1 inhibitors in cancer chemotherapy. Translational Clinical Biology. 1, 1 (Oct. 2013), pp.10–14. DOI:https://doi.org/10.14259/tcb.v1i1.63.